scholarly journals Role of punctal plugs as a primarily treatment modality in moderate to severe dry eye

2020 ◽  
Vol 7 (2) ◽  
pp. 72
Author(s):  
Sonali V. Kumar

<p class="abstract"><strong>Background:</strong> In dry eye syndrome tear film disrupts which lead to ocular discomfort. Treatment of dry eye is very challenging and time consuming. Multiple treatment options are available for treating dry eye and one of them is punctal plugs. It blocks the drainage of tear by occluding puncta which helps in the preservation of natural tears on the ocular surface and relieve dry eye symptoms. This study was conducted to assess the safety and efficacy of punctal plugs as a primary treatment modality in moderate to severe dry eye.</p><p class="abstract"><strong>Methods:</strong> Fifty patients were included in this study and they were divided into two groups. In group A which included 25 patients punctal plugs were inserted and in group B (25 patients or 50 eyes) artificial tear drop was prescribed. The primary treatment outcome was the improvement in dry eye symptoms and secondary outcome was Schirmer test score, tear break up time and rose bengal staining score.</p><p class="abstract"><strong>Results:</strong> There was drastic improvement in dry eye symptoms in group A (punctal plugs) compared to group B (artificial tear group). Schirmer test score, tear break up and rose bengal staining score also improved in punctal plug group.</p><p class="abstract"><strong>Conclusions: </strong>This study has shown that punctal plug can be used as a primary treatment modality in moderate to severe dry eye as it improves greater symptomatic relief and also improves the condition of damaged ocular surface.</p>

2019 ◽  
Vol 13 (1) ◽  
pp. 34-42 ◽  
Author(s):  
Sri Ganesh ◽  
Sheetal Brar ◽  
Sheetal N. Bagare

Purpose: To assess the efficacy of topical cyclosporine 0.05% in the management of cataract surgery induced dry eye. Methods: This prospective, comparative, randomized, interventional study included 67 patients undergoing cataract surgery. The patients were randomized into three categories Group A: patients on topical lubricants and cyclosporine 0.05%, Group B: patients on topical lubricants only and Group C: patients not on any dry eye medication. Patients were given the respective treatment 2 weeks prior and 3 months after cataract surgery, along with an identical perioperative regimen of topical steroids, antibiotics and NSAIDs. Dry eye evaluation done 2 weeks pre-op, 1 week post-op and 3 months post-op consisted of a subjective questionnaire, tear osmolarity, Tear Break Up Time (TBUT) and Schirmer’s 1 without and with anaesthesia. Results: Pre-operatively, all the 3 groups were matched in terms of mean age, tear osmolarity, TBUT and Schirmer’s 1 without and with anaesthesia scores. At 3 months, patients treated with both topical lubricants and cyclosporine (0.05%)(Group A) showed improvement subjective questionnaire, tear osmolarity, TBUT and Schirmer’s 1 tests. Patients treated with lubricants only (Group B) showed a significant worsening in TBUT and tear osmolarity at 1 week, however, the values returned to baseline at 3 months.The control group (Group C) had the worst TBUT scores at the end of 3 months and showed the persistence of raised tear osmolarity, suggestive of a prolonged ocular inflammation resulting in patient dissatisfaction. Conclusion: Topical cyclosporine (0.05%) may be a useful adjuvant to prevent and treat cataract surgery associated with dry eye symptoms, especially in patients with pre-existing dry eye disease.


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 1202-1207
Author(s):  
Pavithra S ◽  
Dheepak Sundar M

To assess dry eye symptoms (DES) and quality of sleep in engineering students during the Covid19 pandemic lockdown and also to assess the association between DES and sleep quality. A cross-sectional questionnaire-based study was carried out among 396 engineering students studying in Saveetha engineering college. The study tool used was a semi-structured google form questionnaire designed for assessing digital device usage, symptoms of dry eye disease and sleep pattern. Responses were analyzed using appropriate statistical tests. Overall 64.1% attained a score of more than 10, indicating the presence of DES. 70.2% of the study population used digital screens for more than 13 hours. A statistically significant association was found between increased screen time and presence of DES(p<0.05). 64.9% had a score of >18 indicating reduced sleep quality. About 77.1% of the students with DES had reduced sleep quality, and a significant association (p<0.01) was observed between the two. During the Covid19 pandemic lockdown, there appears to be rising prevalence of DES in student population, one of the reasons being increased screen time. The sleep quality was also found to be reduced, and a significant association was found between DES and sleep quality.


Author(s):  
Diego García-Ayuso ◽  
Johnny Di Pierdomenico ◽  
Esmeralda Moya-Rodríguez ◽  
Francisco J Valiente-Soriano ◽  
Caridad Galindo-Romero ◽  
...  

2005 ◽  
Vol 31 (1) ◽  
pp. 2-8 ◽  
Author(s):  
Donald R. Korb ◽  
John P. Herman ◽  
Jack V. Greiner ◽  
Robert C. Scaffidi ◽  
Victor M. Finnemore ◽  
...  

2018 ◽  
Vol 44 ◽  
pp. S307-S313 ◽  
Author(s):  
Victoria S. Chang ◽  
Terri P. Rose ◽  
Carol L. Karp ◽  
Roy C. Levitt ◽  
Constantine Sarantopoulos ◽  
...  

2017 ◽  
Vol 43 (3) ◽  
pp. 192-198 ◽  
Author(s):  
Jerry P. Kalangara ◽  
Anat Galor ◽  
Roy C. Levitt ◽  
Derek B. Covington ◽  
Katherine T. McManus ◽  
...  

The Eye ◽  
2021 ◽  
Vol 23 (4) ◽  
pp. 31-34
Author(s):  
M. Conway

The issue of hydrophilicity of the surface of gas permeable contact lenses remains one of the persistent problems. Tangible Hydra-PEG™ surface coating is applied to gas permeable contact lenses to significantly improve wettability and wearing comfort. Although it is mainly used to alleviate dry eye symptoms in scleral and corneal lens users, particularly for those patients with corneal ectasia and/or Ocular Surface Disease (OSD), it can be used in other modalities. This article describes the development of the product and describes the benefits of its use in a clinical case.


Cornea ◽  
2019 ◽  
Vol 38 (1) ◽  
pp. 18-23 ◽  
Author(s):  
Servet Cetinkaya ◽  
Mehmet Gulmez ◽  
Emine Mestan ◽  
Fikret Ucar ◽  
Nermin Ali

Sign in / Sign up

Export Citation Format

Share Document